Congressional Research Service Reports - Browse

ABOUT BROWSE FEED
Medicaid, SCHIP, and Other Health Provisions in H.R. 5661: Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000
This report discusses Medicaid and the State Children’s Health Insurance Program (SCHIP). The report also discusses other major health provisions provisions of H.R. 5661 are incorporated, by reference into H.R. 4577, the Consolidated Appropriations Act 2001.
Patient Protection and Managed Care: Legislation in the 106th Congress
No Description Available.
Medicaid Eligibility for Adults and Children
No Description Available.
Patient Protection and Mandatory External Review: Amending ERISA's Claims Procedure
No Description Available.
Managed Care and State External Review Statutes
No Description Available.
Use of the Annual Appropriations Process to Block Implementation of the Affordable Care Act (FY2011-FY2016)
Congress remains deeply divided over implementation of the Patient Protection and Affordable Care Act (ACA), the health reform law enacted in March 2010. Since the ACA's enactment, lawmakers opposed to specific provisions in the ACA or the entire law have repeatedly debated its implementation and considered bills to repeal, defund, delay, or otherwise amend the law. This report summarizes the ACA-related language added to annual appropriations legislation by congressional appropriators since the ACA was signed into law.
Prescription Drug Coverage Under Medicaid
Medicaid is a joint federal-state entitlement program that pays for medical services on behalf of certain groups of low-income persons. It is the third largest social program in the federal budget, exceeded only by Social Security and Medicare and is typically the second largest spending item for states. This report discusses prescription drug policies under the program.
Prescription Drug Coverage Under Medicaid
Medicaid is a joint federal-state entitlement program that pays for medical services on behalf of certain groups of low-income persons. It is the third largest social program in the federal budget, exceeded only by Social Security and Medicare and is typically the second largest spending item for states. This report discusses prescription drug policies under the program.
Recent Developments in Medicare Affecting Long-Term Care Hospitals
Medicare pays about $36 billion annually for post-acute care in four separate settings: long-term care hospitals (LTCHs), inpatient rehabilitation settings (IRFs), skilled nursing facilities (SNFs), and in the home. This report provides background information on several operational issues affecting LTCHs that are currently attracting attention from Congress, specifically efforts to develop a patient assessment tool, to develop qualification criteria that should be imposed on LTCHs, and to change Medicare’s LTCH payment methods.
Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188): Provisions and Changes to Preexisting Law
No Description Available.
Social Security and Medicare "Lock Boxes"
No Description Available.
Social Security and Medicare "Lock Boxes"
No Description Available.
Use of the Annual Appropriations Process to Block Implementation of the Affordable Care Act (FY2011-FY2017)
This report summarizes the ACA-related language added to annual appropriations legislation by congressional appropriators since the ACA was signed into law. The information is presented in Table 1. While a detailed examination of the ACA itself is beyond the scope of this report, a brief overview of the ACA's core provisions and its impact on federal spending is provided as context for the material in the table.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care: Questions and Answers
No Description Available.
Medicare: Side-by-Side Comparison of Selected Prescription Drug Bills
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Military Medical Care Services: Questions and Answers
No Description Available.
Catastrophic Health Insurance: Medicare
Catastrophic medical costs are broadly defined as large unpredictable health care expenses; these are usually associated with a major illness or serious injury. The absence of catastrophic health insurance protection for the elderly is the subject of concern in this report.
Beneficiary Information and Decision Supports for the Medicare-Endorsed Prescription Drug Discount Card
On December 8, 2003 the President signed into law the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA, P.L. 108-173). This legislation establishes a Medicare prescription drug benefit, effective January 1, 2006. In the interim, the legislation requires the Department of Health and Human Services (HHS) to establish a temporary program of Medicare-endorsed prescription drug discount cards. This report discusses the objectives and benefits of this legislation.
2005 Gulf Coast Hurricanes: The Public Health and Medical Response
In response to a series of disasters (namely, the 2005 Hurricanes Katrina and Rita) and terrorist attacks (namely, the 2001 terror attacks) over the past decade, Congress, the Administration, state and local governments, and the private sector have made investments to improve disaster preparedness and response. New federal authorities and programs to strengthen the nation's public health system were introduced in comprehensive legislation in 2002. Congress also created the Department of Homeland Security (DHS) in 2002, and a new National Response Plan (NRP) was launched by DHS in December 2004. This report discusses the NRP and its components for public health and medical response, provides information on key response activities carried out by agencies in the Department of Health and Human Services (HHS) and DHS, and discusses certain issues in public health and medical preparedness that have been raised by the response to the 2005 Gulf Coast hurricanes.
2005 Gulf Coast Hurricanes: The Public Health and Medical Response
This report discusses the National Response Plan (NRP) and its components for public health and medical response, provides information on key response activities carried out by agencies in the Department of Health and Human Serivces (HHS) and the Department of Homeland Security (DHS), and discusses certain issues in public health and medical preparedness that have been raised by the response to the 2005 Gulf Coast hurricanes.
Flexible Spending Accounts and Medical Savings Accounts: A Comparison
No Description Available.
Flexible Spending Accounts and Medical Savings Accounts: A Comparison
No Description Available.
Flexible Spending Accounts and Medical Savings Accounts: A Comparison
No Description Available.
Flexible Spending Accounts and Medical Savings Accounts: A Comparison
No Description Available.
Flexible Spending Accounts and Medical Savings Accounts: A Comparison
No Description Available.
Bioterrorism: Legislation to Improve Public Health Preparedness and Response Capacity
This report shows that while lawmakers work towards final passage of new authorizing legislation, Congress has appropriated more than $3 billion to the Dept. of Health and Human Services (HHS) to increase bioterrorism preparedness at the federal, state, and local levels. HHS anti-bioterrorism funding was included in the FY2002 Labor-HHSEducation appropriations bill and in the $20 billion emergency spending package that was attached to the FY2002 Defense appropriations bill. Until the new authorizing legislation is enacted, HHS is dispersing the funds according to existing authorities and the broad parameters set out in the appropriations bills.
Medicaid Reimbursement Policy
This report begins with a summary of basic federal requirements applicable to payments for all services and an overview of major developments in federal Medicaid reimbursement policy over the last 20 years. This overview provides a historical context for current policies and highlights some issues that have been perennial concerns for federal and state policymakers. The next four sections of the report provide a detailed discussion of Medicaid reimbursement for four basic categories of services or providers.
Bisphenol A (BPA) in Plastics and Possible Human Health Effects
Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Bisphenol A (BPA) in Plastics and Possible Human Health Effects
Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Bisphenol A (BPA) in Plastics and Possible Human Health Effects
Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Patient Protection and Managed Care: Legislation in the 107th Congress
No Description Available.